Millipore agrees to buy cell biology firm
Millipore Corp., a Billerica company that provides tools and services to the life sciences industry, said it has agreed to buy Guava Technologies for $22.6 million in a bid to expand its cell biology offerings.
Based in California, Guava had about $22 million in sales in 2008 and is a provider of bench-top cell analysis systems, Millipore said.
"The transaction is expected to be slightly accretive to Millipore's non-GAAP earnings per share during 2009 and is expected to close in the next two weeks," Millipore said in a press release.
"With the Guava acquisition, we will bring the power of our flow cytometry platform to all cell biologists by combining Guava's instruments with our broad range of fully-validated reagent kits," Martin Madaus, chairman and chief executive of Millipore, said in a statement.
To read the company's press release, please click here.
(By Chris Reidy, Globe staff)